News

Jefferies Downgrades Mondelez Due to Cocoa Supply Concerns

Jefferies Downgrades Mondelez Due to Cocoa Supply Concerns

Concerns Over Cocoa Supply Prompt Downgrade of Mondelez

Jefferies has made a significant shift in its outlook for Mondelez International (NASDAQ: MDLZ), moving from a Buy to a Hold rating. This decision stems from growing apprehensions regarding cocoa supply constraints that pose a potential threat to the company’s earnings moving forward.

Challenges in Cocoa Production

Weather and Other Factors Impacting Yield

The analysts at Jefferies are particularly focused on the ongoing challenges in cocoa production, especially in key areas of West Africa, which are recognized for their role in global cocoa supply. Reports indicate that the current cocoa season has been marred by weather irregularities, leading to an upsurge in diseases affecting crops, which have devastated up to 25% of cocoa trees in pivotal countries.

Impact on Global Cocoa Supply

Countries such as Ivory Coast and Ghana, which together represent a significant share of the world’s cocoa production, have experienced a shortfall of around 675,000 tons compared to last year's figures. Jefferies warns that if another deficit year occurs, it could lead to sustained elevated cocoa prices, raising concerns about the stability of global cocoa supplies.

Rising Cocoa Prices and Financial Projections

Future Earnings at Risk

As cocoa futures prices surge, especially with forecasts predicting prices could soar to $7,400 per ton by 2026, Mondelez faces challenging forecasts for its 2025 and 2026 earnings. This is particularly troubling as Jefferies had originally anticipated cocoa prices would stabilize around $5,000 per ton.

Concerns About Growth Targets

Despite Mondelez's strong market position, evidenced by its foothold in emerging markets and robust balance sheet, Jefferies has voiced skepticism regarding the company's ability to achieve its organic growth targets. The valuation for Mondelez has been adjusted to reflect its circumstances, now standing at 18 times its estimated earnings for 2026, a decline from previous valuations.

Market Resilience and Pricing Strategies

European Chocolate Demand

On a more positive note, the demand for chocolate within the European market has remained steady. Mondelez is actively working to adapt to these market conditions by introducing tiered pricing strategies aimed at retaining consumer affordability.

Looking Ahead

While there are glimmers of resilience in certain markets, Jefferies maintains a cautious outlook regarding the broader challenges Mondelez faces, suggesting that the cocoa supply situation could heavily impact the company's performance in the near future.

Frequently Asked Questions

What caused Jefferies to downgrade Mondelez?

Jefferies downgraded Mondelez due to increasing concerns over cocoa supply constraints affecting future earnings.

How much of the cocoa supply is affected?

Approximately 675,000 tons of cocoa supply is reported to be shortfall compared to the previous season, especially in Ivory Coast and Ghana.

What are the financial implications for Mondelez?

With rising cocoa prices, Mondelez's earnings projections for 2025 and 2026 are at risk, as prices are expected to remain elevated.

What strategies is Mondelez implementing in response?

Mondelez is planning to introduce tiered pricing to help maintain consumer affordability amid the challenges.

How does cocoa supply affect chocolate prices?

A deficit in cocoa supply can lead to higher cocoa prices, which in turn can increase the cost of chocolate products for consumers.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 22

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading
Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 16

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading
Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 24

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading
Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 14

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 19

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading
LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 25

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 20

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading

Top 5 Most Recently Viewed Articles

Suntory Spirits Partners with IG Arena for Exciting Ventures

Updated Category News Views 148

Suntory Spirits Partners with IG Arena for a Historic Collaboration Suntory Spirits Ltd., recognized as a prominent player in the global beverage industry, is making headlines with its recent collaboration with Aichi International Arena Co., Ltd. This partnership establishes Suntory as a "Founding Partner" of IG Arena, a state-of-the-art multisport facility anticipated to...

Continue Reading
Vranken-Pommery Unveils 2024 Financial Insights for Investors

Updated Category News Views 134

Availability of the 2024 Half-Year Financial Report Today, the Vranken-Pommery Monopole Group has presented its half-year financial report to the Autorité des Marchés Financiers (AMF). This marks an important milestone for the company. The report serves as a vital resource for investors, providing in-depth insights into the company's performance during the first half of...

Continue Reading
Fnac Darty Extends Unieuro Share Sale Deadline to December

Updated Category News Views 93

Fnac Darty's Tender Offer for Unieuro Shares Progresses In a significant move for shareholders, Fnac Darty SA, in conjunction with RUBY Equity Investment S.à r.l., has extended the period for the public tender and exchange offer aimed at acquiring all shares of Unieuro S.p.A. This extension is particularly crucial for those holders of remaining shares, offering them...

Continue Reading
Unison Offers Affordable Home Equity Loans Amid Economic Strain

Updated Category News Views 159

Unison Reduces Home Equity Loan Rates for Financial Relief As economic uncertainties persist, many American families are feeling the pinch of inflation and market instability. In response, Unison Mortgage Corporation has introduced a significant reduction in the Annual Percentage Rate (APR) for their Equity Sharing Home Loan. This new rate, starting as low as 5.34% for...

Continue Reading
Soligenix Hits Snags but Eyes Future Moves

Updated Category News Views 10

The Current Landscape of Soligenix Sure, it's not all sunshine and rainbows for Soligenix right now. They just announced the end of the line for their HyBryte™ program. It's a bummer when a Phase 3 ends not with a bang but with a whimper. The FLASH2 study didn't deliver the goods, leaving HyBryte™, that synthetic hypericin wonder, on the cutting room floor. But hey,...

Continue Reading